Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice
- 31 May 2005
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 180 (1) , 45-53
- https://doi.org/10.1016/j.atherosclerosis.2004.12.025
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Deficiency of cathepsin S reduces atherosclerosis in LDL receptor–deficient miceJournal of Clinical Investigation, 2003
- Differential Expression of Cysteine and Aspartic Proteases during Progression of Atherosclerosis in Apolipoprotein E-Deficient MiceThe American Journal of Pathology, 2002
- Matrix Metalloproteinases in Vascular Remodeling and AtherogenesisCirculation Research, 2002
- Cystatin C deficiency in human atherosclerosis and aortic aneurysmsJournal of Clinical Investigation, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells.Journal of Clinical Investigation, 1998
- Function of the Plasminogen/Plasmin and Matrix Metalloproteinase Systems After Vascular Injury in Mice With Targeted Inactivation of Fibrinolytic System GenesArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formationNature Genetics, 1997
- Identification of Cystatin C, a Cysteine Proteinase Inhibitor, as a Major Secretory Product of Human Alveolar MacrophagesIn VitroAmerican Review of Respiratory Disease, 1990
- Constitutive secretion of cystatin C (gamma-trace) by monocytes and macrophages and its downregulation after stimulation.The Journal of Experimental Medicine, 1987